Richard A. Edlin's most recent trade in Eagle Pharmaceuticals Inc was a trade of 16,253 Stock Option (right to buy) done . Disclosure was reported to the exchange on March 7, 2023.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Eagle Pharmaceuticals Inc | Richard A. Edlin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Mar 2023 | 16,253 | 16,253 | - | - | Stock Option (right to buy) | |
| Eagle Pharmaceuticals Inc | Richard A. Edlin | Director | Sale of securities on an exchange or to another person at price $ 30.99 per share. | 06 Sep 2022 | 6,800 | 22,600 (0%) | 0% | 31.0 | 210,732 | Common Stock |
| Eagle Pharmaceuticals Inc | Richard A. Edlin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2022 | 11,200 | 11,200 | - | - | Stock Option (right to buy) | |
| Eagle Pharmaceuticals Inc | Richard A. Edlin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Feb 2021 | 13,500 | 13,500 | - | - | Stock Option (right to buy) |